Company overview
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing DERM with another company.
| Daily close (USD) | $6.31 |
| Market capitalization (USD) | $178,095,932.45 |
| Price / earnings (TTM) | Not reported |
| Price / book | 5.55 |
No matching rows. Clear the filter to see all records.
Read DERM's valuation metrics
Company size
Journey Medical Corporation Common Stock's recorded market capitalization is $178,095,932.45. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
DERM's recorded price-to-book ratio is 5.55. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Journey Medical Corporation Common Stock with Aurora
Use the snapshot above to ask a specific question about DERM. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow DERM's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.